Alpha Score of 36 reflects weak overall profile with poor momentum, weak value, moderate quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.
Medtronic plc (MDT) currently trades at a price-to-earnings ratio of 35.68, reflecting its position within the healthcare sector. The company reported a year-over-year revenue growth rate of 6.9% alongside an EPS growth rate of 8.9%, supported by a net margin of 13.0%. With an EPS of 2.47, the stock is currently positioned within its 52-week range of $80.68 to $105.35. The Alpha Score for the ticker stands at 50.1, indicating a balanced profile across key metrics. Specifically, the momentum sub-score is 53.6, while the quality and sentiment scores are 51 and 50, respectively. The value sub-score of 45.4 suggests the current pricing relative to earnings remains a focal point for market participants evaluating the company's fundamental performance. These figures highlight a period of consistent operational expansion as the firm navigates its current fiscal environment. Investors should continue to monitor the company's ability to maintain these growth margins throughout the remainder of the current quarter.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 1.6K | $161K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 30.6K | $3.0M |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 19.3K | $1.9M |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 668 | $65K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 385 | $38K |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 24.2K | $2.5M |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 1.9K | $198K |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 2.0K | $204K |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 825 | $84K |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 227 | $23K |
Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solutions, rhythm management, surgery, coronary and renal denervation, mechanical circulatory support, peripheral vascular health, structural heart and aortic products; Diabetes, offering therapies and services for insulin-dependent individuals with Type 1 and Type 2 diabetes; Medical Surgical, encompassing surgical endoscopy and acute care and monitoring; and Restorative Therapies, covering cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. Medtronic plc produces innovative products such as implantable pacemakers, cardioverter-defibrillators, spinal cord stimulators, insulin pumps, and remote monitoring systems, serving patients in hospitals, homes, and surgical settings worldwide. Founded in 1949 and legally headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, it focuses on advancing healthcare through minimally invasive therapies, disease management, and patient monitoring technologies in more than 150 countries.
Earnings calendar coming soon. Subscribe to get notified when MDT reports next.
Get earnings alerts →